We have added a new amino acid mutation, Gly13Cys, to our SensiScreen® KRAS EXON 2 assays. The new mutation is developed and are being validated within the next month. The new mutation will be added to our KRAS EXON 2 Multiplex (K1 & K2) and KRAS EXON 2 Simplex (K6) after validation.
In 2017 we launched our MSI Multiplex for easy testing. By reducing the number of tubes from 10 to 2, we have reduced hands-on-time and made the process easier.
Our MSI Multiplex is available as ready-to-use, and can be purchases from our distributors or directly at www.pentanbase.com.